NK-1 receptor active amine oxide prodrugs
US6897226B2 · kind B2 · utility
0Cited by
7References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 9, 2003 |
| Grant date | May 24, 2005 |
| Priority date | — |
| Expiry date | Aug 15, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the invention are amine oxide prodrugs showing activity on the NK1 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.